Hard though it is to believe, there is another issue facing outpatient imaging centers besides the Deficit Reduction Act, information technology, and turf wars. It’s the multimodality revolution, which encompasses plain film x-ray, ultrasound, and yes, even mammography.
Hard though it is to believe, there is another issue facing outpatient imaging centers besides the Deficit Reduction Act, information technology, and turf wars. It's the multimodality revolution, which encompasses plain film x-ray, ultrasound, and yes, even mammography. For years, these modalities have taken a backseat to MRI, CT, and PET because of their poor reimbursement and risk-reward profiles. As sales have slowed in expensive modalities, x-ray, ultrasound, and mammography are finding their way back into the outpatient imaging arena. And vendors have a newfound chance to grow their business as this revolution escalates.
As crazy as it sounds, this seems to be working. One outpatient business owner I know began with x-ray and ultrasound to establish his businesses model and contracts. Now he is looking at adding modalities such as PET, MRI, and CT. Starting with x-ray and ultrasound, he told me, allowed him to test the market before leaping into higher end modalities.
This has by no means been the usual approach. For years, many outpatient centers focused on MRI, CT, or both while ignoring other modalities. One reason is that a limited-modality model requires less square footage to operate and, depending on the modality chosen, can garner high reimbursements at low operating costs. Now outpatient centers must have at least three modalities in a center to hold on to payer contracts. Mammography, x-ray, and ultrasound offer poor reimbursement and can break even only when high volumes are achieved. X-ray and mammography require that 20+ studies be performed daily to reach the break even point, but there must be room for them. Most single-modality MR and CT centers are not designed to accommodate more modalities, even though it would mean another 15 to 20 patients in the waiting room.
The upside is that adding these modalities not only keeps a center contracted with payers, but also helps to actually grow business for other modalities. Payers are requiring plain films and conservative care before authorizing MRI or CT, forcing centers to also offer those more conservative modalities. Multimodality centers are now becoming the first point of contact for the patient. And patients are more likely to return to a center for any follow-up studies once their demographics?? are in the system.
These new multimodality requirements are forcing centers to add technologies if they want to stay in business. At Liberty Pacific Medical Management, a provider of operational consultancy and management support services, we have been advising our customers to negotiate with vendors in advance. This encourages them to find economical solutions that will benefit their CT or MRI business as well as help them remain engaged in payer contracts. For example, ultrasound is an excellent supplement to a 64-slice CT, while mammography is a good addition to any breast MRI program.
This sea change has opened new doors for many vendors and given them an edge. They are well positioned to ensure their modalities are appropriately placed in centers.
To seize the opportunity and assure they get the sale, vendors must work with single-modality centers by assisting them in the following areas:
Essentially, vendors have the chance to strike right now, while the iron is hot and while the multimodality revolution is gaining traction. With rapid expansion in the diagnostic imaging arena comes an opportunity to shape the future of outpatient center offerings. Why not tout the solution to a captive and highly receptive audience?
Steven R. Renard is president and chief operating officer of Encino, CA-based Liberty Pacific Medical Imaging, which owns and operates medical diagnostic imaging centers, primarily in California. Liberty Pacific also provides third-party management, consulting, and medical development services.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.